BeStock  
Stocks › Biotechnology › QURE

uniQure NV QURE

US equityMarket cap rank #2941Biotechnology
$22.80 −$0.66 (-2.81%)
Market closed · Oct 6, 2:50 am ET · Last extended-hours $22.57 -1.03%
Open$22.28
Prev close$23.46
Day range$21.37 – $23.24
Volume3.04M
Market cap$1.58B
P/E (TTM)–
Dividend yield–

Price chart

Daily bars for up to one year, weekly bars for the 5-year view. Averages are 50/200 trading days (10/40 weeks on the 5-year view). Triangles mark past earnings reports, colored by that day’s move; ticks mark ex-dividend dates — hover either for the date. Volume is the shaded bars under the price; switch on RSI or MACD above for a full-history oscillator panel, not just today’s reading.

Community Sentiment on QURE

No votes yet — be the first to weigh in.

Reader sentiment, not investment advice. One vote per visitor; click again to change it.

QURE at a glance

QURE last changed hands at $22.80 (down 2.81%). At $1.58B, uniQure NV is ranked #2941 by size among the 3132 stocks on BeStock.

The stock's 52-week band runs $8.73 to $71.50, and the latest print sits 68.1% under the top end of it. Holders are behind 56.9% over twelve months, and down 44.9% across the last three months.

On the chart it has slipped under both the 50-day ($42.86) and 200-day ($29.73) moving averages; RSI is 17, which some call oversold, and the last 30 sessions moved at roughly 142% annualized volatility.

9 analysts follow the stock and the average call is "buy". The mean target, $54.50, sits 139.0% over where the stock trades.

This summary is put together from the numbers on the page and updates when they do. It describes the data; it is not a forecast or a recommendation.

BeStock Grade

D
BeStock Grade

Composite of 3 factors below, ranked against the 3132 U.S. stocks BeStock covers.

C
Valuation

Cheaper than usual on its own 5-year P/E history scores higher.

F
Momentum

Trading closer to its 52-week high than most peers scores higher.

B
Wall Street

9 analysts, consensus Buy.

How this is scored: each factor above is a 0–100 percentile rank against every other stock BeStock covers (or, for Wall Street, against the five-point Strong Buy–Sell scale). The overall grade is the plain average of whichever factors apply to this stock — no factor is weighted more than another. That average maps to a letter: A ≥ 85, B ≥ 70, C ≥ 50, D ≥ 30, otherwise F. Recomputed from the data on this page as prices and filings update — it describes where a stock ranks today, not a forecast, and not a BeStock recommendation to buy or sell.

QURE is not currently one of the 10 holdings in BeStock Momentum, our rules-based momentum strategy.

Since 2021-01-04, the strategy has returned 389% (231.1% for the equal-weight average of BeStock’s coverage over the same stretch). Holdings can change any trading day, not just on a fixed schedule. Backtested performance, updated weekly — not a guarantee of future results, and not a BeStock recommendation.

Price forecast

What Wall Street analysts and Morningstar's fair-value model expect for the stock

Analyst price target (avg)$54.50+139.0% vs. current price
Consensus ratingBuy9 analysts covering
Morningstar fair value$29.26Price is below fair value

Wall Street’s average 12-month target is $54.50, 139.0% above today’s price, with a consensus rating of Buy. Morningstar’s fair value model puts the stock at $29.26, so shares trade 22.1% below that estimate. On earnings multiple, it sits in the 31st percentile of its own five-year valuation range (cheaper than usual).

Figures are Wall Street analyst consensus and Morningstar’s independent fair-value model, sourced as noted above.

Performance

Price return over each window, from adjusted daily and weekly closes

1 day
-2.8%
1 week
-41.7%
1 month
-49.2%
3 months
-44.9%
6 months
+31.1%
Year to date
-4.7%
1 year
-56.9%
Day range
$21.37$23.24
52-week range
$8.73$71.50

Technical signals

Full technicals →
Trend readStrong downtrend

1 bullish · 5 bearish of 7 signals

IndicatorValueSignal
Price vs 20-day average-40.4%Bearish
Price vs 50-day average-46.8%Bearish
Price vs 200-day average-23.3%Bearish
50-day vs 200-day50d above 200dBullish
RSI (14)16.6Neutral
MACD (12,26,9)-5.66Bearish
Bollinger band position7%Bearish

Standard indicator readings worked out from daily closes. They describe how the price has behaved, not where it is going.

Key statistics

Bid / Ask$22.56 / $23.04
Average price today$22.52
Volume3.04MAvg (90d) 2.18M
Turnover$68.50M
Turnover rate5.29%of shares outstanding
Volume ratio0.32vs. recent average pace
Day amplitude7.97%
Market cap$1.58B
Float market cap$1.31B
Shares outstanding57.53M
EPS (TTM)-$3.46
P/B4.88
Book value / share$4.67
Earnings yield-0.87%
Net profit (TTM)-$240.01M
Net assets$324.08M
30-day volatility142.1%annualized
Avg daily range (ATR)14.01%of price, 14 days
Max drawdown (1y)-87.2%-67.7% from 1y peak

Quote as of Oct 6, 2026 2:50 am ET. Prices can lag the live tape. This is background information, not a recommendation.

How QURE ranks on BeStock

Market value#2941 of 3132
Closeness to 52-week high#3089 of 3127
Dollar volume today#1215 of 3132

Ranks are among the 3,132 or so U.S.-listed stocks BeStock covers, recalculated whenever prices refresh. A tile is left out when the measure does not apply, such as yield for a stock that pays no dividend.

QURE stock: common questions

How is uniQure NV stock doing today?

$22.80 is the latest print for QURE, a move of -2.81% against yesterday's close of $23.46. Today's low and high so far: $21.37 and $23.24.

How big is uniQure NV?

Equity value comes to $1.58B at the current price. By that measure it is number 2941 of the 3132 names in our coverage.

Where does QURE sit in its 52-week range?

The year's floor is $8.73 and the ceiling $71.50. Shares are 68.1% away from that ceiling.

Does QURE send cash back through a dividend?

Our data shows no dividend paid by uniQure NV over the trailing twelve months.

Do Wall Street analysts like QURE?

Of 9 analysts, 78% say buy, 22% hold and 0% sell. Price targets average $54.50, with the most cautious at $28.00 and the most optimistic at $80.00.

BeStock publishes market data and analysis for information only. Nothing here is investment advice or a solicitation to buy or sell any security, and none of it is tailored to your financial situation, goals, or risk tolerance. Quotes may be delayed and figures can contain errors; check primary sources before you trade. How we source and calculate these pages.

Discussion

No comments yet — be the first to weigh in on QURE.

Leave a comment

Scroll to Top